| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.05. | Kda Group Announces Results Of Shareholders' Annual General Meeting And The Settlement Of Judicial Claims | 1 | CNW | ||
| 10.04. | KDA Group Inc: KDA appoints Kirouac as chief technology officer of GTK | 1 | Stockwatch | ||
| 09.04. | Kda Group Announces The Appointment Of Martin Kirouac As Chief Technology Officer Of Its Subsidiary Groupe Technologique Kda | 1 | CNW | ||
| 25.03. | KDA Group Inc: KDA Group closes acquisition of GTK interest | 4 | Stockwatch | ||
| 24.03. | Kda Group Announces The Acquisition Of The Minority Interest In Its Subsidiary Groupe Technologique Kda Inc. | 1 | CNW | ||
| 24.12.25 | KDA Group Inc: KDA obtains conditional TSX-V OK for GTK share purchase | 1 | Stockwatch | ||
| 22.12.25 | Kda Group Announces A Collaboration To Integrate New Clinical Alerts Into The Medherize Platform To Support The Adoption Of Next-generation Sequencing For Breast Cancer Patients | 1 | CNW | ||
| 03.12.25 | Kda Group Announces Partnership Agreement With Chu De Québec-université Laval For The Deployment Of Medherize | 1 | CNW | ||
| KDA GROUP Aktie jetzt für 0€ handeln | |||||
| 01.12.25 | Kda Group Deploys Medherize Across Community Pharmacies: A Major Step Forward In The Management Of Oral Anticancer Therapies | 1 | CNW | ||
| 26.11.25 | KDA Group To Acquire 20% Stake In Subsidiary GTK From ERxpert | 1 | RTTNews | ||
| 26.11.25 | KDA Group Inc: KDA Group to acquire 20% of ERxpert subsidiary | 2 | Stockwatch | ||
| 25.11.25 | Kda Group Announces Agreement To Acquire Minority Interest In Its Subsidiary Groupe Technologique Kda Inc. | 1 | CNW | ||
| 18.11.25 | KDA Group Inc: KDA Group opens U.S. subsidiary for Medherize launch | 1 | Stockwatch | ||
| 17.11.25 | Kda Group Opens A U.s. Subsidiary And Accelerates The Growth Of Its Medherize Solution | 1 | CNW |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,660 | +1,05 % | Fresenius Medical Care: Anleger bleiben trotz Sparkurs skeptisch | Trotz eines überraschend stabilen operativen Ergebnisses rutscht die Aktie nach Vorlage der Quartalszahlen deutlich ab. Wechselkurse und hohe Kosten setzen dem Konzern weiter zu, während das Management... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,720 | +12,36 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| UNITEDHEALTH | 338,40 | +3,68 % | Unitedhealth im freien Fall: Droht jetzt der nächste große Absturz? - Handeln Sie, bevor es zu spät ist | ||
| HIMS & HERS HEALTH | 21,380 | -13,65 % | Earnings Preview: Nebius, Hims & Hers, Cisco & Co. Welche Zahlen diese Woche spannend werden! | © Foto: Yuki Iwamura - AP/dpa +++ dpa-Bildfunk +++Diese in den kommenden Tagen (KW20) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell... ► Artikel lesen | |
| BICO GROUP | 1,656 | -6,23 % | BICO Group AB: Bulletin from the Annual General Meeting in BICO Group AB (publ) | The following resolutions were passed at the Annual General Meeting (the "AGM") of BICO Group AB (publ) ("BICO" or the "Company") held today on 7 May 2026 in Gothenburg, Sweden.
Adoption of Income Statement... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,015 | -3,85 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| UNIDOC HEALTH | 0,070 | -4,38 % | UniDoc Health Corp.: UniDoc to Update and Relaunch Legacy eHealth Systems with Pawnee Mental Health Services Across Rural Kansas | Ex-AMD Telemedicine account aims to relaunch utilizing UniDoc Connect-enabled eHealth system VANCOUVER, BC / ACCESS Newswire / May 7, 2026 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc"... ► Artikel lesen | |
| VERU | 2,270 | +2,71 % | Veru Inc.: Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th | ||
| BONESUPPORT | 21,980 | +1,76 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q1 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the first quarter 2026.
"Solid start to 2026 - strong growth... ► Artikel lesen | |
| CLARIANE | 4,144 | -0,62 % | Clariane: Minutes of the General Meeting of 12 May 2026 | Minutes of the General Meeting of 12 May 2026 Paris, 12 May 2026 - The Annual General Meeting of shareholders of Clariane (CLARI - ISIN: FR0010386334) was held on 12 May 2026 (the « General Meeting... ► Artikel lesen | |
| VIROMED MEDICAL | 6,800 | -1,45 % | Viromed Medical AG: MDR IIa-Meilenstein erreicht, Prognosen angepasst, adj. est., KAUFEN | Viromed hat einen wichtigen regulatorischen Meilenstein erreicht, indem es die MDR-Klassifizierung IIa für ViroCAP med erhalten hat, was es dem Unternehmen ermöglicht, das Gerät zur Wundbehandlung in... ► Artikel lesen | |
| SENSEONICS | 4,680 | -4,49 % | H.C. Wainwright cuts Senseonics stock price target on dilution | ||
| BEYOND AIR | 0,531 | +2,10 % | Beyond Air: Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 | Updated AACR poster data show continued survival follow-up in heavily pre- treated patients following a single intratumoral UNO injection Received US patent allowance covering proprietary gas delivery... ► Artikel lesen | |
| M3 INC | 7,268 | -0,16 % | M3, Inc. Reports Increase In Full Year Profit | TOKYO (dpa-AFX) - M3, Inc. (4YC.F) reported earnings for its full year that Increased, from last yearThe company's bottom line came in at JPY49.100 billion, or JPY72.50 per share. This compares... ► Artikel lesen | |
| NANALYSIS SCIENTIFIC | 0,096 | +4,14 % | Nanalysis Scientific Corp.: Nanalysis Announces Fourth Quarter and Full Year 2025 Results | Reports Quarterly Revenue of $10.7 Million and Adjusted EBITDA of $1.2 Million
Full Year Revenue of $40.1 Million and Adjusted EBITDA of $903 Thousand
CALGARY,... ► Artikel lesen |